Intensity modulated radiation therapy after extra‐pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival

Intensity modulated radiation therapy after extra‐pleural pneumonectomy for malignant pleural... 1INTRODUCTIONMalignant pleural mesothelioma (MPM) is a rare but deadly malignant neoplasm arising in the pleura with approximately 2500 cases diagnosed annually in the United States and a median survival of 12 months (median survival in most series is 4–20 months). Asbestos exposure remains the greatest risk factor with 70–80% of MPM patients having documented exposure to asbestos: men are more commonly affected than women.The management of MPM is challenging and controversial. Broadly, there is debate regarding the optimal surgical approach of extrapleural pneumonectomy (EPP) versus lung sparing approaches, such as pleurectomy and decortication (P/D). Unfortunately, regardless of the surgical approach, relapse is common after surgery and is predominantly loco‐regional with subsequent dismal outcomes. Aggressive local therapy with surgery followed by adjuvant radiation plays a major role in the multimodal management to improve local control.The delivery of radiation therapy has improved over time from 3‐D conformal techniques to intensity modulated radiation therapy (IMRT). However, initial experience with IMRT was fraught with very high rates of fatal pulmonary toxicity. The increasing experience with IMRT treatment planning and delivery has improved our understanding of acceptable lung dose constraints. Strict adherence to these published lung dose constraints in subsequent studies has resulted in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Asia-Pacific Journal of Clinical Oncology Wiley

Intensity modulated radiation therapy after extra‐pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival

Loading next page...
 
/lp/wiley/intensity-modulated-radiation-therapy-after-extra-pleural-GwAKjvSO7i
Publisher
Wiley
Copyright
Copyright © 2018 John Wiley & Sons Australia, Ltd
ISSN
1743-7555
eISSN
1743-7563
D.O.I.
10.1111/ajco.12680
Publisher site
See Article on Publisher Site

Abstract

1INTRODUCTIONMalignant pleural mesothelioma (MPM) is a rare but deadly malignant neoplasm arising in the pleura with approximately 2500 cases diagnosed annually in the United States and a median survival of 12 months (median survival in most series is 4–20 months). Asbestos exposure remains the greatest risk factor with 70–80% of MPM patients having documented exposure to asbestos: men are more commonly affected than women.The management of MPM is challenging and controversial. Broadly, there is debate regarding the optimal surgical approach of extrapleural pneumonectomy (EPP) versus lung sparing approaches, such as pleurectomy and decortication (P/D). Unfortunately, regardless of the surgical approach, relapse is common after surgery and is predominantly loco‐regional with subsequent dismal outcomes. Aggressive local therapy with surgery followed by adjuvant radiation plays a major role in the multimodal management to improve local control.The delivery of radiation therapy has improved over time from 3‐D conformal techniques to intensity modulated radiation therapy (IMRT). However, initial experience with IMRT was fraught with very high rates of fatal pulmonary toxicity. The increasing experience with IMRT treatment planning and delivery has improved our understanding of acceptable lung dose constraints. Strict adherence to these published lung dose constraints in subsequent studies has resulted in

Journal

Asia-Pacific Journal of Clinical OncologyWiley

Published: Jan 1, 2018

Keywords: ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off